Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 32
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Obes (Lond) ; 35(12): 1530-8, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21343904

RESUMO

AIMS: This study investigated the effects of indole-3-carbinol (I3C), a compound from cruciferous vegetables, on various parameters related to obesity, in particular, the parameters of infiltration by macrophages and of inflammatory cytokines expressed during the co-culture of adipocytes and macrophages. METHODS: Male C57BL/6 mice were fed with a control diet (C group), high-fat diet (HF group) and HF+5 mg kg(-1) I3C (HFI group). The I3C was intraperitoneally injected (HFI group) for 12 weeks. Epididymal adipose tissue (AT) was collected and stained for F4/80, a marker of macrophages. RESULTS: The immunohistochemical staining for F4/80 indicated a greater presence of macrophages in the HF group than in AT from the control and HFI groups. Furthermore, I3C treatment, in an in vitro cell culture system, decreased expression of inducible nitric oxide synthase (iNOS), decreased nitrite content and enhanced expression of peroxisome proliferator-activated receptor (PPAR-γ). Moreover, in vitro cell culture studies revealed that I3C inhibited intracellular lipid accumulation in hypertrophied adipocytes. In macrophage and primary adipocyte co-culture, I3C inhibited expression of interleukin-6 (IL-6). CONCLUSIONS: In vivo treatment with I3C reduced the infiltration of macrophages in AT, and in vitro addition of I3C to co-cultured macrophages and adipocytes reduced nitrite production and IL-6 expression. With cultures of adipocytes only, I3C inhibited accumulation of intracellular lipid, either by disrupting differentiation, or by directly inhibiting triglyceride synthesis.


Assuntos
Adipócitos/metabolismo , Tecido Adiposo/metabolismo , Fármacos Antiobesidade/farmacologia , Indóis/farmacologia , Interleucina-6/metabolismo , Macrófagos/metabolismo , Nitritos/metabolismo , Obesidade/tratamento farmacológico , Extratos Vegetais/farmacologia , Adipócitos/efeitos dos fármacos , Tecido Adiposo/efeitos dos fármacos , Tecido Adiposo/patologia , Animais , Peso Corporal/efeitos dos fármacos , Técnicas de Cocultura , Dieta Hiperlipídica , Imuno-Histoquímica , Macrófagos/efeitos dos fármacos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Tamanho do Órgão/efeitos dos fármacos , Reação em Cadeia da Polimerase Via Transcriptase Reversa
2.
Br J Anaesth ; 96(5): 597-601, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16531447

RESUMO

BACKGROUND: Group I metabotropic glutamate receptors (mGluRs) have been reported to regulate N-methyl-d-aspartate (NMDA) receptor function in various brain regions. The selective mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) can potentiate NMDA antagonists such as PCP and MK-801-induced behavioural responses. In the present study, the role of group I mGluRs on ketamine- and propofol-induced general anaesthesia was examined. METHODS: Mice were pretreated with various doses of the group I mGluR agonist (S)-3,5-dihydroxyphenylglycine (DHPG), selective mGluR5 agonist (RS)-2-chloro-5-hydroxyphenylglycine (CHPG), mGluR1 antagonist 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt) and mGluR5 antagonist MPEP followed by administration of ketamine (120 mg kg(-1)) or propofol (140 mg kg(-1)) to induce anaesthesia. The duration of loss of righting reflex was recorded. RESULTS: DHPG and CHPG antagonized and MPEP potentiated ketamine-induced anaesthesia in a dose-dependent manner. CPCCOEt was ineffective. However, propofol-induced anaesthesia was not affected after manipulating mGluR1 and mGluR5 receptors. CONCLUSIONS: mGluR5 receptors play an important role in modulation of anaesthesia induced by ketamine, but not propofol.


Assuntos
Anestésicos Intravenosos/farmacologia , Ketamina/farmacologia , Propofol/farmacologia , Receptores de Glutamato Metabotrópico/fisiologia , Anestésicos Dissociativos/farmacologia , Animais , Cromonas/farmacologia , Relação Dose-Resposta a Droga , Glicina/análogos & derivados , Glicina/farmacologia , Ketamina/agonistas , Ketamina/antagonistas & inibidores , Masculino , Metoxi-Hidroxifenilglicol/análogos & derivados , Metoxi-Hidroxifenilglicol/farmacologia , Camundongos , Fenilacetatos/farmacologia , Propofol/antagonistas & inibidores , Piridinas/farmacologia , Receptor de Glutamato Metabotrópico 5 , Receptores de Glutamato Metabotrópico/agonistas , Receptores de Glutamato Metabotrópico/antagonistas & inibidores , Reflexo/efeitos dos fármacos
3.
Phys Rev Lett ; 75(20): 3705-3708, 1995 Nov 13.
Artigo em Inglês | MEDLINE | ID: mdl-10059706
5.
Phys Rev Lett ; 71(23): 3822-3825, 1993 Dec 06.
Artigo em Inglês | MEDLINE | ID: mdl-10055082
6.
Phys Rev Lett ; 71(14): 2268-2271, 1993 Oct 04.
Artigo em Inglês | MEDLINE | ID: mdl-10054630
7.
Phys Rev B Condens Matter ; 48(9): 5741-5750, 1993 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-10009106
8.
Phys Rev Lett ; 70(12): 1854-1857, 1993 Mar 22.
Artigo em Inglês | MEDLINE | ID: mdl-10053403
9.
Phys Rev Lett ; 70(7): 954-957, 1993 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-10054247
10.
Phys Rev B Condens Matter ; 45(16): 9347-9356, 1992 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-10000798
11.
Phys Rev Lett ; 68(1): 60-63, 1992 Jan 06.
Artigo em Inglês | MEDLINE | ID: mdl-10045112
12.
Phys Rev Lett ; 67(14): 1821-1824, 1991 Sep 30.
Artigo em Inglês | MEDLINE | ID: mdl-10044259
13.
Phys Rev Lett ; 65(20): 2567-2570, 1990 Nov 12.
Artigo em Inglês | MEDLINE | ID: mdl-10042630
14.
Phys Rev Lett ; 64(18): 2148-2151, 1990 Apr 30.
Artigo em Inglês | MEDLINE | ID: mdl-10041596
16.
Phys Rev Lett ; 64(8): 979, 1990 Feb 19.
Artigo em Inglês | MEDLINE | ID: mdl-10042130
17.
Phys Rev Lett ; 62(12): 1372-1375, 1989 Mar 20.
Artigo em Inglês | MEDLINE | ID: mdl-10039657
18.
Phys Rev B Condens Matter ; 38(13): 8760-8766, 1988 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-9945653
19.
20.
Phys Rev Lett ; 61(17): 1950-1953, 1988 Oct 24.
Artigo em Inglês | MEDLINE | ID: mdl-10038940
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...